Marcus E. Randall, MD, FACR, FASTRO, is chair and professor of radiation medicine at the University of Kentucky where he holds the Markey Foundation Chair. A national leader in gynecologic radiation oncology, he served as professor and chair of the Department of Radiation Oncology at Indiana University School of Medicine, where he held the William A. Mitchell Professorship, prior to coming to UK in 2006.
Before completing his residency in radiation oncology at the University of Virginia, Dr. Randall earned his MD and undergraduate degree in Chemistry at the University of North Carolina, Chapel Hill. In 2017, he received the Distinguished Alumnus Award from the UNC School of Medicine. He is board certified by the American Board of Radiology and a Fellow of the American College of Radiology and American Society for Therapeutic Radiology and Oncology.
Within the Gynecologic Oncology Group, Dr. Randall has led national trials in endometrial and ovarian cancers, chaired the NRG Oncology research organization, and co-chaired the Uterine Corpus Committee. His clinical interests include brachytherapy and gynecologic malignancies.
Outside of work, Dr. Randall enjoys reading, travel, and spending time with his family, which includes three beautiful grandchildren.
Personal Statement: "Every day at UK is different, and I enjoy all aspects of it…patient care, education, clinical research. I enjoy getting the team to work together toward common goals that deliver great care to our patients, train the next generation of the radiation oncology workforce, and find new and better ways to care for patients, not just here at UK, but around the world. When everyone is working together (which we do very well here), it is really beautiful to watch."
Faculty RankProfessor of Radiation Medicine
MD, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill
University of Virginia Medical Center, Charlottesville
Certifications and Special Training
American Board of Radiology
Fellow of the American College of Radiology
Fellow of the American Society for Therapeutic Radiology and Oncology
- Principles and Practice of Gynecologic Oncology, 5th edition Barakat R, Markman M, and Randall M, eds., Lippincott, Williams, and Wilkins, 2009.
- Does the progression-free interval after primary chemotherapy predict survival following salvage chemotherapy in advanced and recurrent endometrial cancer? A Gynecologic Oncology Group (GOG) ancillary data analysis Moore KN, Tian C, McMeekin DS, McMeekin DS, Thigpen JT, Randall ME, Gallion HE. Cancer 116:5407-14, 2010.
- Adjuvant treatment for stage IIIC endometrial cancer: Options and controversies. Shah PH, Kudrimoti M, Feddock J, Randall M. Gynecol Oncol 122:675-83, 2011.
- Association of number of positive nodes and cervical stromal invasion with outcome of advanced endometrial cancer treated with chemotherapy or whole abdominal irradiation: A Gynecologic Oncology Group (GOG) study. Tewari KS, Filiaci VL, Spirtos NM, Mannel RS, Thigpen JT, Cibull ML, Monk BJ, Randall ME. Gynecol Oncol 125 87-93, 2012.
- Primary radiation therapy for medically inoperable patients with clinical stage I and II endometrial carcinoma. Podzielinski I, Randall ME, Breheny PJ, Escobar PF, Cohn DE, Quick AM, Chino JP, Lopez-Acevedo M, Seitz JL, Zook JE, Seamon LG. Gynecol Oncol 124:36-41, 2012.
Cancer Center Member
- Translational Oncology
College & Department
- College of Medicine
- Department of Radiation Medicine
Gynecologic Oncology Clinic
UK Markey Cancer CenterWhitney-Hendrickson BuildingFax 859-323-1602800 Rose St.
Third Floor, Room 330A
Lexington, KY 40536
A parking lot is located near the Whitney-Hendrickson Building, accessible via Hospital Drive. Get directions to Whitney-Hendrickson.
Insurance policies can vary widely. Please check with your doctor/clinic for specific insurance information before your visit or procedure to avoid unexpected out-of-pocket costs. See list of insurers